Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck

Clinical trial NCT00057512 · COMPLETED

Trial details

NCT number: NCT00057512
Sponsor: Erimos Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Neoplasms

Start date: 2003-01-01
Primary completion: 2003-12-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.